Join to View Full Profile
1204 W Main StCharlottesville, VA 22903
Phone+1 434-924-0123
Fax+1 434-243-3300
Dr. Lee is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 2008 - 2012
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2008 - 2011
University of Texas Health Science Center at HoustonResidency, Pediatrics, 2005 - 2008
University of Texas M.D. Anderson Cancer CenterPost-Doctoral Fellowship, 2003 - 2005
McGovern Medical School at UTHealthClass of 2003, MD
Certifications & Licensure
VA State Medical License 2016 - 2026
MD State Medical License 2008 - 2016
TX State Medical License Active through 2012
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma Start of enrollment: 2012 Jun 29
- Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma Start of enrollment: 2014 Nov 01
- Study Evaluating Brexucabtagene Autoleucel (KTE-X19) in Pediatric and Adolescent Participants With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia or Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Start of enrollment: 2016 Feb 01
Publications & Presentations
PubMed
- 6 citationsTargeting refractory/recurrent neuroblastoma and osteosarcoma with anti-CD3×anti-GD2 bispecific antibody armed T cells.Maxim Yankelevich, Archana Thakur, Shakeel Modak, Roland Chu, Jeffrey Taub
Journal for Immunotherapy of Cancer. 2024-03-21 - 8 citationsIntrathecal hydrocortisone for treatment of children and young adults with CAR T-cell immune-effector cell-associated neurotoxicity syndrome.Haneen Shalabi, Cynthia Harrison, Bonnie Yates, Katherine R Calvo, Daniel W Lee
Pediatric Blood & Cancer. 2024-01-01 - 10 citationsA U.S. Food and Drug Administration-pooled Analysis of Frontline Combination Treatment Survival Benefits by Risk Groups in Metastatic Renal Cell Carcinoma.Daniel Lee, Haley Gittleman, Chana Weinstock, Daniel Suzman, Erik Bloomquist
European Urology. 2023-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
